NLRP3 and chronic myelogenous leukemia, BCR-ABL1 positive: Further, recent studies also indicate that NLRP3 inflammasome activation has been implicated in various types of leukemia, including myelodysplastic syndrome, myeloproliferative neoplasms, AML, CML, and ALL [51,52,53].